Clinical Trials in Minneapolis

Showing 621-640 of 6,957 trials

Colorectal Cancer Legal and Administrative Burden Support: A Pilot Clinical Trial

NCT06475664

This is a single center single-arm, pilot study of proactive and early connection with free legal care services for persons with advanced colorectal cancer to assess the feasibility, acceptability, and preliminary efficacy of this intervention in improving financial and psychosocial outcomes. Participants will receive free, personalized legal care services from Cancer Legal Care (CLC), a nonprofit organization located in the Twin Cities of Minnesota. The duration of study participation is 6 months, however, participants may continue to access free personalized legal care services beyond this period. All participants continue to receive standard of care as prescribed by their treating physician.

Colorectal Cancer

University of Minnesota20 participantsStarted Aug 2024

Minneapolis, Minnesota, United States

RECRUITINGPHASE2< 1 mile

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

NCT05535166

This is a multi-center, multinational phase 2 trial that aims to explore the use of molecular and clinical risk-directed therapy in treatment of children 0-4.99 years of age with newly diagnosed medulloblastoma.

Medulloblastoma

St. Jude Children's Research Hospital130 participantsStarted Dec 2022

Palo Alto, California, United States • Orlando, Florida, United States • Tampa, Florida, United States +7 more locations

Colorectal Cancer Legal and Administrative Burden Support: A Pilot Clinical Trial

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Find Trials by Condition in Minneapolis

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

Understanding Needs of Older Patients Prior to Starting Cancer Treatment

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

A Study of AZD0120 in Autoimmune Diseases

An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

A Study of Navenibart in Participants With Hereditary Angioedema

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma